Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AK31
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 106 | 110 | PF00656 | 0.535 |
CLV_C14_Caspase3-7 | 119 | 123 | PF00656 | 0.533 |
CLV_NRD_NRD_1 | 14 | 16 | PF00675 | 0.467 |
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.566 |
CLV_NRD_NRD_1 | 193 | 195 | PF00675 | 0.683 |
CLV_NRD_NRD_1 | 213 | 215 | PF00675 | 0.495 |
CLV_NRD_NRD_1 | 273 | 275 | PF00675 | 0.755 |
CLV_NRD_NRD_1 | 311 | 313 | PF00675 | 0.596 |
CLV_NRD_NRD_1 | 70 | 72 | PF00675 | 0.622 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.445 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.566 |
CLV_PCSK_KEX2_1 | 193 | 195 | PF00082 | 0.683 |
CLV_PCSK_KEX2_1 | 27 | 29 | PF00082 | 0.444 |
CLV_PCSK_PC1ET2_1 | 27 | 29 | PF00082 | 0.466 |
DEG_APCC_DBOX_1 | 78 | 86 | PF00400 | 0.600 |
DEG_SPOP_SBC_1 | 230 | 234 | PF00917 | 0.630 |
DEG_SPOP_SBC_1 | 318 | 322 | PF00917 | 0.484 |
DOC_CYCLIN_RxL_1 | 28 | 39 | PF00134 | 0.540 |
DOC_MAPK_gen_1 | 34 | 40 | PF00069 | 0.487 |
DOC_PP2B_LxvP_1 | 95 | 98 | PF13499 | 0.502 |
DOC_PP4_FxxP_1 | 58 | 61 | PF00568 | 0.507 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.484 |
DOC_USP7_MATH_1 | 222 | 226 | PF00917 | 0.680 |
DOC_USP7_MATH_1 | 231 | 235 | PF00917 | 0.639 |
DOC_USP7_MATH_1 | 318 | 322 | PF00917 | 0.594 |
DOC_USP7_UBL2_3 | 200 | 204 | PF12436 | 0.664 |
DOC_USP7_UBL2_3 | 290 | 294 | PF12436 | 0.686 |
DOC_USP7_UBL2_3 | 309 | 313 | PF12436 | 0.566 |
DOC_USP7_UBL2_3 | 319 | 323 | PF12436 | 0.640 |
LIG_14-3-3_CanoR_1 | 302 | 310 | PF00244 | 0.708 |
LIG_Actin_WH2_2 | 78 | 96 | PF00022 | 0.587 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.458 |
LIG_BIR_III_2 | 189 | 193 | PF00653 | 0.649 |
LIG_FHA_1 | 21 | 27 | PF00498 | 0.549 |
LIG_FHA_1 | 299 | 305 | PF00498 | 0.559 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.545 |
LIG_FHA_2 | 104 | 110 | PF00498 | 0.545 |
LIG_FHA_2 | 131 | 137 | PF00498 | 0.502 |
LIG_LIR_Apic_2 | 86 | 92 | PF02991 | 0.478 |
LIG_LIR_Gen_1 | 115 | 126 | PF02991 | 0.498 |
LIG_LIR_Gen_1 | 53 | 63 | PF02991 | 0.510 |
LIG_LIR_Nem_3 | 115 | 121 | PF02991 | 0.517 |
LIG_LIR_Nem_3 | 53 | 59 | PF02991 | 0.549 |
LIG_LIR_Nem_3 | 7 | 12 | PF02991 | 0.457 |
LIG_NRP_CendR_1 | 323 | 324 | PF00754 | 0.647 |
LIG_PTB_Apo_2 | 81 | 88 | PF02174 | 0.404 |
LIG_PTB_Phospho_1 | 81 | 87 | PF10480 | 0.403 |
LIG_SH2_CRK | 89 | 93 | PF00017 | 0.594 |
LIG_SH2_NCK_1 | 118 | 122 | PF00017 | 0.608 |
LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.730 |
LIG_SH2_STAT5 | 89 | 92 | PF00017 | 0.571 |
LIG_SH3_2 | 49 | 54 | PF14604 | 0.605 |
LIG_SH3_3 | 105 | 111 | PF00018 | 0.554 |
LIG_SH3_3 | 46 | 52 | PF00018 | 0.575 |
LIG_TRAF2_1 | 162 | 165 | PF00917 | 0.511 |
LIG_TRAF2_1 | 48 | 51 | PF00917 | 0.604 |
LIG_TYR_ITIM | 116 | 121 | PF00017 | 0.612 |
MOD_CK1_1 | 149 | 155 | PF00069 | 0.508 |
MOD_CK1_1 | 168 | 174 | PF00069 | 0.484 |
MOD_CK1_1 | 226 | 232 | PF00069 | 0.679 |
MOD_CK1_1 | 269 | 275 | PF00069 | 0.668 |
MOD_CK1_1 | 298 | 304 | PF00069 | 0.618 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.441 |
MOD_GlcNHglycan | 150 | 154 | PF01048 | 0.654 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.705 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.737 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.750 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.589 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.587 |
MOD_GlcNHglycan | 298 | 301 | PF01048 | 0.520 |
MOD_GlcNHglycan | 305 | 308 | PF01048 | 0.541 |
MOD_GlcNHglycan | 44 | 47 | PF01048 | 0.546 |
MOD_GSK3_1 | 222 | 229 | PF00069 | 0.676 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.612 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.425 |
MOD_N-GLC_1 | 168 | 173 | PF02516 | 0.618 |
MOD_N-GLC_1 | 276 | 281 | PF02516 | 0.552 |
MOD_N-GLC_1 | 83 | 88 | PF02516 | 0.648 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.459 |
MOD_NEK2_1 | 295 | 300 | PF00069 | 0.664 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.571 |
MOD_NEK2_2 | 22 | 27 | PF00069 | 0.535 |
MOD_PK_1 | 205 | 211 | PF00069 | 0.612 |
MOD_PKA_1 | 205 | 211 | PF00069 | 0.666 |
MOD_PKA_2 | 146 | 152 | PF00069 | 0.430 |
MOD_Plk_1 | 36 | 42 | PF00069 | 0.545 |
MOD_Plk_1 | 83 | 89 | PF00069 | 0.506 |
MOD_Plk_4 | 112 | 118 | PF00069 | 0.540 |
MOD_Plk_4 | 276 | 282 | PF00069 | 0.553 |
TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.609 |
TRG_ER_diArg_1 | 14 | 17 | PF00400 | 0.468 |
TRG_ER_diArg_1 | 192 | 194 | PF00400 | 0.656 |
TRG_NLS_Bipartite_1 | 10 | 31 | PF00514 | 0.453 |
TRG_NLS_Bipartite_1 | 193 | 208 | PF00514 | 0.778 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1II41 | Leptomonas seymouri | 62% | 100% |
A0A1X0NL53 | Trypanosomatidae | 39% | 100% |
A0A3S7WNR7 | Leishmania donovani | 90% | 100% |
A4H3W9 | Leishmania braziliensis | 76% | 100% |
A4HS44 | Leishmania infantum | 89% | 100% |
O97206 | Leishmania major | 86% | 98% |
V5B9E1 | Trypanosoma cruzi | 38% | 100% |